Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.72 |
| ▸ | MEN1 | O00255 | 3/20 | 0.72 |
| ▸ | HBB | P68871 | 2/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.71 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.50 |
| ▸ | PNP | P00491 | 7/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | BLM | P54132 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | EDNRA | P25101 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | HPRT1 | P00492 | 4/20 | 0.41 |
| ▸ | POLG | P54098 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | VCP | P55072 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Valacyclovir SCHEMBL4295083 | 1.00 | KMT2A (0.72) | KMT2AMEN1HBBMAPK1PDE3A | |
| Valacyclovir SCHEMBL29689659 | 0.99 | HBB (0.72) | KMT2AMEN1HBBMAPK1PDE3A | |
| Valacyclovir SCHEMBL1888797 | 0.98 | KMT2A (0.69) | KMT2AMEN1HBBMAPK1PDE3A | |
| SCHEMBL23948433 | 0.86 | KMT2A (0.53) | KMT2AMEN1HBBMAPK1PDE3A | |
| Valacyclovir SCHEMBL20570801 | 0.85 | MEN1 (0.75) | KMT2AMEN1HBBMAPK1PDE3A | |
| Valganciclovir SCHEMBL336814 | 0.85 | PDE3A (0.78) | KMT2AMEN1HBBMAPK1PDE3A | |
| Valacyclovir SCHEMBL4656778 | 0.84 | MEN1 (1.00) | KMT2AMEN1HBBMAPK1PDE3A | |
| Valacyclovir SCHEMBL8444387 | 0.84 | MEN1 (1.00) | KMT2AMEN1HBBMAPK1PDE3A | |
| Valacyclovir SCHEMBL13575743 | 0.84 | MEN1 (1.00) | KMT2AMEN1HBBMAPK1PDE3A | |
| Valacyclovir SCHEMBL28644 | 0.84 | MEN1 (1.00) | KMT2AMEN1HBBMAPK1PDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 14378 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139860-A1 | PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS | CENTRE FOR DIGESTIVE DISEASES (AU) | 2026-05-21 | — | — | US | claimed |
| EP-4094767-B1 | NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | UNIV EMORY (US) | 2026-05-20 | — | — | EP | claimed |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4731194-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP Technologies, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-3790536-B1 | NANOCONTAINERS FOR TRANSPORTING NONPOLAR, LIPOPHILIC SUBSTANCES SUCH AS ANTIBIOTICS | KARLSRUHER INST TECHNOLOGIE (DE) | 2026-04-22 | — | — | EP | claimed |
| US-20260102422-A1 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | UNIV EMORY (US) | 2026-04-16 | — | — | US | claimed |
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| US-12595280-B2 | Phosphoramidates for the treatment of hepatitis B virus | EMORY UNIVERSITY (US) | 2026-04-07 | — | — | US | claimed |
| EP-0806943-A1 | VALACICLOVIR TABLETS CONTAINING COLLOIDAL SILICON DIOXIDE | THE WELLCOME FOUNDATION LIMITED (GB) | 1997-11-19 | — | — | EP | claimed |
| EP-0804436-A1 | GUANINE DERIVATIVE | THE WELLCOME FOUNDATION LIMITED (GB) | 1997-11-05 | — | — | EP | claimed |
| WO-1997026882-A1 | NUCLEOSIDE ANALOGS IN COMBINATION THERAPY OF HERPES SIMPLEX INFECTIONS | SMITHKLINE BEECHAM PLC (GB) | 1997-07-31 | — | — | WO | claimed |
| WO-1997025989-A1 | USE OF VALACICLOVIR FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF GENITAL HERPES BY A SINGLE DAILY APPLICATION | GLAXO GROUP LIMITED (GB) | 1997-07-24 | — | — | WO | claimed |
| WO-1996024354-A1 | NOVEL PHARMACEUTICAL COMPOSITION | ASTRA AKTIEBOLAG (SE) | 1996-08-15 | — | — | WO | claimed |
| EP-0723448-A1 | USE OF PENICLORIN FOR THE TREATMENT OF POSTTHERAPEUTIC NEURALGIA | SMITHKLINE BEECHAM PLC (GB) | 1996-07-31 | — | — | EP | claimed |
| WO-1996022291-A1 | GUANINE DERIVATIVE | THE WELLCOME FOUNDATION LIMITED (GB) | 1996-07-25 | — | — | WO | claimed |
| WO-1996022082-A1 | VALACICLOVIR TABLETS CONTAINING COLLOIDAL SILICON DIOXIDE | THE WELLCOME FOUNDATION LIMITED (GB) | 1996-07-25 | — | — | WO | claimed |
| WO-1995011027-A1 | USE OF PENICLORIN FOR THE TREATMENT OF POSTTHERAPEUTIC NEURALGIA | SMITHKLINE BEECHAM PLC (GB) | 1995-04-27 | — | — | WO | claimed |
| WO-1995005179-A1 | THERAPEUTIC COMBINATION CONTAINING AN ANTI-VARICELLA ZOSTER VIRUS COMPOUND AND LAMOTRIGINE | THE WELLCOME FOUNDATION LIMITED (GB) | 1995-02-23 | — | — | WO | claimed |